Transparency in drug regulation: mirage or oasis?

MeSH terms

• Access to Information / legislation & jurisprudence*
• Antidepressive Agents / therapeutic use
• Bias
• Canada
• Cardiovascular Diseases / chemically induced
• Celecoxib
• Clinical Trials as Topic / standards
• Cyclooxygenase Inhibitors / adverse effects
• Drug Approval / organization & administration*
• Drug Industry / legislation & jurisprudence*
• Hormone Replacement Therapy / adverse effects
• Humans
• Publishing / standards
• Pyrazoles
• Sulfonamides / adverse effects